SpotSee-Controlant Collaboration Addresses Shipment Monitoring Gaps in Temperature-Sensitive Supply Chains

This week, SpotSee and Controlant have announced a strategic collaboration designed to address visibility gaps in the life sciences supply chain by integrating hardware-based monitoring with cloud-based analytics.¹ The initiative seeks to establish a more rigorous proof of condition for therapies as they move from manufacturing facilities to the final point of care.

“The market is clear: customers need automated data sharing and continuous, end-to-end visibility,” said Controlant CEO Gísli Herjólfsson.¹

The partnership intends to provide that visibility by merging real-time monitoring capabilities with scalable physical indicators, allowing pharmaceutical manufacturers to better manage risk across shipments.¹ By bridging the gap between transit data and last-mile verification, the organizations aim to support monitoring programs that can scale efficiently without increasing the operational burden on logistics providers.

How Do Integrated Monitoring and Indicator Technologies Ensure Supply Chain Integrity?

The primary technical framework of this collaboration is a "layered monitoring approach" that utilizes both real-time connected devices and shipment-level indicator technology.¹ This dual-layer system allows organizations to optimize their monitoring investments by applying different levels of technology depending on the value and sensitivity of the cargo. While real-time IoT devices offer continuous environmental data during transit, secondary indicators provide a cost-effective method for verifying conditions at the individual package level upon delivery.¹

As part of this rollout, a co-branded Controlant Go device has been released to simplify real-time connectivity for high-value pharmaceutical logistics. Furthermore, the technical roadmap for 2026 includes a software-level integration between SpotSee’s WarmMark QR temperature indicators and the Controlant cloud platform. Once implemented, this integration will allow QR-based temperature data to be uploaded directly into existing cloud visibility and quality management workflows.¹

Herjólfsson emphasized the scalability of this model, stating, “By working with SpotSee, we can extend monitoring strategies beyond devices alone and support last-mile proof that's ready to scale from day one without the heavy lifting.”¹

What are the Operational Impacts and Risk Mitigation Benefits for Life Sciences Distribution?

The partnership is specifically designed to meet the needs of pharmaceutical manufacturers, specialty logistics providers, and cold chain operators who must navigate increasingly complex global networks. According to the IQVIA Institute for Human Data Science, failures in cold chain handling cost the pharmaceutical industry an estimated $35 billion each year.²

In an industry where environmental excursions can lead to significant financial loss and potential patient safety issues, the ability to provide undeniable proof of condition is a critical requirement.

SpotSee CEO Tony Fonk identified the specific logistical gaps the partnership intends to fill, noting the collaboration “closes the monitoring gaps from pallet to patient.”¹ Fonk stated that “By combining last-mile, indicator-based monitoring with real-time connected devices and cloud analytics, customers can build programs that reduce returns by as much as 90% and significantly improve patient satisfaction.”¹

SpotSee and Controlant have officially moved into the of joint customer engagement phase and are actively deploying these integrated monitoring programs. The move toward cloud-integrated indicators represents a shift toward more holistic, data-centric pharmaceutical commerce, where the primary objective is ensuring that every therapy reaches its destination in optimal condition.

References

1. SpotSee and Controlant Announce Strategic Collaboration to Expand Shipment Visibility and Last-Mile Proof for Life Sciences. SpotSee website. Published March 2, 2026. Accessed March 3, 2026. https://spotsee.io/blog/spotsee-and-controlant-announce-strategic-collaboration-to-expand-shipment-visibility-and-last-mile-proof-for-life-sciences/
2. Pelican Biothermal. 2019 Biopharma Cold-Chain Logistics Survey: What Matters Most — and What it Means for the Future. Pelican Biothermal; 2019. Accessed March 3, 2026. https://cdn2.hubspot.net/hubfs/4107558/general%20content/PEL1046_SurveyReport_v4a.pdf